Home > Insider Trading > Filing (0001127602-15-004354)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494892	Frank Haluska	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139	Svp, Clinical R&D, Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-02	29,334	$0.00	124,633	No	4	M	Direct
Common Stock	Disposition	2015-02-02	16,134	$6.33	108,499	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2015-02-02	29,334	$0.00	29,334	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
58,666		2024-01-31	No	4	M	Direct

Footnotes

Shares were acquired upon vesting of restricted stock units awarded on January 31, 2014.
Represents shares withheld to satisfy witholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
Each restricted stock unit represents a right to receive one share of ARIAD common stock.
The restricted stock units vest as to one-third of the units on each of the first, second and third anniversaries of the date of the award (January 31,2014).
The restricted stock units vested on January 31, 2015.